Operable Breast Cancer with Positive Axillary Nodes: The Experience of the Milan Cancer Institute

  • P. Valagussa
  • A. Rossi
  • G. Bonadonna
Conference paper
Part of the Lecture Notes in Medical Informatics book series (LNMED, volume 4)


The course of breast cancer following potentially curative local-regional modality, i.e. radical mastectomy (RM) plus or minus postoperative irradiation (RT), has been critically re-evaluated during the past few years. The analysis of prospective controlled studies (4,6) has clearly indicated the limits of treatment based only on anatomical principles (5). Furthermore, the histological status of axillary lymph nodes has proved to be the single most useful prognostic factor in women with operable breast cancer. In fact, slightly less than one fourth of women with histologically positive axillary nodes (N+) remained relapse-free at 10 years compared to about three fourths of patients with negative nodes (N-) (4,6).


Combination Chemotherapy Radical Mastectomy Operable Breast Cancer Prospective Control Study Positive Axillary Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bonadonna G., Brusamolino E., Valagussa P., et al.: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N. Engl. J. Med. 294: 405–410, 1976.PubMedCrossRefGoogle Scholar
  2. 2.
    Bonadonna, G., Valagussa, P., Rossi, A., et al,: Are surgical adjuvant trials altering the course of breast cancer? Semin.Oncol, 1978 (in press)Google Scholar
  3. 3.
    Fischer, B., Carbone, P., Economou S.G., et al.: L - phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N. Engl. J.Med. 292: 117–122, 1975.CrossRefGoogle Scholar
  4. 4.
    Fischer, B., Slack, N., Katrych, D.L., et al.: Ten year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg. Gynecol. Obstet. 140: 528–534, 1975Google Scholar
  5. 5.
    Fischer, B.: Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer 40: 574–587, 1977.CrossRefGoogle Scholar
  6. 6.
    Valagussa, P., Bonadonna, G., Veronesi U.: Pattern of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41: 1170–1178, 1978.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1979

Authors and Affiliations

  • P. Valagussa
    • 1
  • A. Rossi
    • 1
  • G. Bonadonna
    • 1
  1. 1.Istituto Nazionale TumoriMilanItaly

Personalised recommendations